Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

BUY
$273.83 - $305.53 $16,977 - $18,942
62 Added 0.73%
8,500 $2.51 Million
Q2 2022

Aug 11, 2022

BUY
$234.96 - $292.55 $732,840 - $912,463
3,119 Added 58.64%
8,438 $2.36 Million
Q1 2022

May 09, 2022

BUY
$221.42 - $260.97 $40,962 - $48,279
185 Added 3.6%
5,319 $1.39 Million
Q4 2021

Feb 10, 2022

BUY
$177.01 - $223.45 $3,540 - $4,469
20 Added 0.39%
5,134 $1.14 Million
Q3 2021

Nov 12, 2021

SELL
$181.39 - $202.99 $23,580 - $26,388
-130 Reduced 2.48%
5,114 $921,000
Q2 2021

Aug 11, 2021

BUY
$187.49 - $221.1 $983,197 - $1.16 Million
5,244 New
5,244 $1.06 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $133B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Opseu Pension Plan Trust Fund Portfolio

Follow Opseu Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opseu Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Opseu Pension Plan Trust Fund with notifications on news.